About This Initiative

Many pharmacists may not realize atrial fibrillation (AF), in particular nonvalvular atrial fibrillation (NVAF), is often not diagnosed even in patients with comorbid conditions, such as hypertension, diabetes, hyperlipidemia, and cardiovascular disease. The underserved are a high-risk population in general and are particularly at risk for having undiagnosed AF. Many of these individuals are reluctant to see a physician, but have relatively easy access to pharmacists in their communities. Opportunistic screening for NVAF, which can be performed by pharmacists, would lead to detection and appropriate management.

On-Demand Activity


Hidden in Plain Sight: Does My Patient Have Nonvalvular Atrial Fibrillation?
Atrial fibrillation (AF)—the most common sustained heart rhythm disorder— is emerging as a growing epidemic. More importantly, a significant number of people remain undiagnosed, putting them at risk for stroke. This educational activity spotlights the need for awareness of nonvalvular atrial fibrillation (NVAF) in patients with risk factors. The role of pharmacists in opportunistic and systemic screening for NVAF is explained, particularly in patients who are underserved. Current guidelines for appropriate, evidence-based therapy for NVAF, including anticoagulation, is also reviewed.

Access Now

On-Demand Activity


Shining a Light on Undiagnosed Nonvalvular Atrial Fibrillation: A Case-based Approach to Care
Nonvalvular atrial fibrillation (NVAF) is often undiagnosed and therefore untreated, leaving patients at risk for stroke. Using diverse patient cases, this activity highlights the lack of awareness of NVAF as a potential diagnosis in patients with comorbidities and in underserved communities. Patient cases illustrate the pharmacist’s role in opportunistic and systemic screening for NVAF, working collaboratively among healthcare providers to ensure that patients receive timely guideline-directed therapy, and engaging patients, caregivers, and family members in ongoing contact and therapeutic monitoring that will lead to improved patient outcomes.

Access Now

Expert Insight Commentaries


Practical commentary from our expert faculty to improve patient outcomes and inspire practice changes.

 

Finding Undiagnosed Atrial Fibrillation: Why, What, Who and How
James S. Kalus, PharmD, FASHP

 

The Time is Now: Equity in the Prescribing of DOACs for NVAF
Devin Lavender, PharmD, BCPS, BCACP

 

 

 

Read Now!